GILEAD SCIENCES, INC. Depreciation
GILEAD SCIENCES, INC. (GILD) reported Depreciation of $98.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-06
- GILEAD SCIENCES, INC. depreciation for the quarter ending 2026-06-30 was $98.00M, a 5.38% increase year-over-year.
- GILEAD SCIENCES, INC. depreciation for the quarter ending 2026-03-31 was $93.00M, a 4.12% decline year-over-year.
- GILEAD SCIENCES, INC. depreciation for the quarter ending 2025-12-31 was $90.00M, a 5.26% decline year-over-year.
- GILEAD SCIENCES, INC. depreciation for the quarter ending 2025-09-30 was $90.00M, a 4.26% decline year-over-year.
- GILEAD SCIENCES, INC. depreciation for fiscal 2025 was $370.00M, a 2.89% decline from fiscal 2024.
- GILEAD SCIENCES, INC. depreciation for fiscal 2024 was $381.00M, a 7.63% increase from fiscal 2023.
- GILEAD SCIENCES, INC. depreciation for fiscal 2023 was $354.00M, a 9.60% increase from fiscal 2022.
- GILEAD SCIENCES, INC. depreciation for fiscal 2022 was $323.00M, a 1.82% decline from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $98.00M 10-Q · filed 2026-08-06 | $191.00M 10-Q · filed 2026-08-06 | $281.00M derived: sum of 3 quarters · filed 2026-08-06 | $371.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $93.00M 10-Q · filed 2026-05-07 | $183.00M derived: sum of 2 quarters · filed 2026-05-07 | $273.00M derived: sum of 3 quarters · filed 2026-05-07 | $366.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $90.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $180.00M derived: sum of 2 quarters · filed 2026-02-24 | $273.00M derived: sum of 3 quarters · filed 2026-08-06 | $370.00M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $90.00M 10-Q · filed 2025-11-07 | $183.00M derived: sum of 2 quarters · filed 2026-08-06 | $280.00M 10-Q · filed 2025-11-07 | $375.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $93.00M 10-Q · filed 2026-08-06 | $190.00M 10-Q · filed 2026-08-06 | $285.00M derived: sum of 3 quarters · filed 2026-08-06 | $379.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $97.00M 10-Q · filed 2026-05-07 | $192.00M derived: sum of 2 quarters · filed 2026-05-07 | $286.00M derived: sum of 3 quarters · filed 2026-05-07 | $384.00M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $95.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $189.00M derived: sum of 2 quarters · filed 2026-02-24 | $287.00M derived: sum of 3 quarters · filed 2026-02-24 | $381.00M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $94.00M 10-Q · filed 2025-11-07 | $192.00M derived: sum of 2 quarters · filed 2025-11-07 | $286.00M 10-Q · filed 2025-11-07 | $377.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $98.00M 10-Q · filed 2025-08-07 | $192.00M 10-Q · filed 2025-08-07 | $283.00M derived: sum of 3 quarters · filed 2026-02-24 | $369.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $94.00M 10-Q · filed 2025-05-07 | $185.00M derived: sum of 2 quarters · filed 2026-02-24 | $271.00M derived: sum of 3 quarters · filed 2026-02-24 | $354.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $91.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $177.00M derived: sum of 2 quarters · filed 2026-02-24 | $260.00M derived: sum of 3 quarters · filed 2026-02-24 | $354.00M 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $86.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $169.00M derived: sum of 2 quarters · filed 2024-11-12 | $263.00M 10-Q · filed 2024-11-12 | $346.00M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-06-30 | $83.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $177.00M 10-Q · filed 2024-08-08 | $260.00M derived: sum of 3 quarters · filed 2025-02-28 | $340.00M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-03-31 | $94.00M 10-Q · filed 2024-05-08 | $177.00M derived: sum of 2 quarters · filed 2025-02-28 | $257.00M derived: sum of 3 quarters · filed 2025-02-28 | $337.00M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $83.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $163.00M derived: sum of 2 quarters · filed 2025-02-28 | $243.00M derived: sum of 3 quarters · filed 2025-02-28 | $323.00M 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | $80.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $160.00M derived: sum of 2 quarters · filed 2023-11-07 | $240.00M 10-Q · filed 2023-11-07 | $330.00M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-06-30 | $80.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $160.00M 10-Q · filed 2023-08-04 | $250.00M derived: sum of 3 quarters · filed 2024-02-23 | $332.00M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-03-31 | $80.00M 10-Q · filed 2023-05-03 | $170.00M derived: sum of 2 quarters · filed 2024-02-23 | $252.00M derived: sum of 3 quarters · filed 2024-02-23 | $331.00M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2021-12-31 | $90.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $172.00M derived: sum of 2 quarters · filed 2024-02-23 | $251.00M derived: sum of 3 quarters · filed 2024-02-23 | $329.00M 10-K · filed 2024-02-23 | ||||
| 2021-09-30 | $82.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $161.00M derived: sum of 2 quarters · filed 2022-11-02 | $239.00M 10-Q · filed 2022-11-02 | $318.00M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | $79.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $157.00M 10-Q · filed 2022-08-08 | $236.00M derived: sum of 3 quarters · filed 2023-02-22 | $309.00M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | $78.00M 10-Q · filed 2022-05-04 | $157.00M derived: sum of 2 quarters · filed 2023-02-22 | $230.00M derived: sum of 3 quarters · filed 2023-02-22 | $298.00M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $79.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $152.00M derived: sum of 2 quarters · filed 2023-02-22 | $220.00M derived: sum of 3 quarters · filed 2023-02-22 | $288.00M 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | $73.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $141.00M derived: sum of 2 quarters · filed 2021-11-03 | $209.00M 10-Q · filed 2021-11-03 | $278.00M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-06-30 | $68.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $136.00M 10-Q · filed 2021-08-05 | $205.00M derived: sum of 3 quarters · filed 2022-02-23 | $271.00M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-03-31 | $68.00M 10-Q · filed 2021-05-06 | $137.00M derived: sum of 2 quarters · filed 2022-02-23 | $203.00M derived: sum of 3 quarters · filed 2022-02-23 | $263.00M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2019-12-31 | $69.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $135.00M derived: sum of 2 quarters · filed 2022-02-23 | $195.00M derived: sum of 3 quarters · filed 2022-02-23 | $255.00M 10-K · filed 2022-02-23 | ||||
| 2019-09-30 | $66.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $126.00M derived: sum of 2 quarters · filed 2020-11-04 | $186.00M 10-Q · filed 2020-11-04 | $243.00M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $60.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $120.00M 10-Q · filed 2020-08-06 | $177.00M derived: sum of 3 quarters · filed 2021-02-25 | $234.00M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $60.00M 10-Q · filed 2020-05-06 | $117.00M derived: sum of 2 quarters · filed 2021-02-25 | $174.00M derived: sum of 3 quarters · filed 2021-02-25 | $230.00M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $57.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $114.00M derived: sum of 2 quarters · filed 2021-02-25 | $170.00M derived: sum of 3 quarters · filed 2021-02-25 | $226.00M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $57.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $113.00M derived: sum of 2 quarters · filed 2019-11-05 | $169.00M 10-Q · filed 2019-11-05 | $247.00M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-06-30 | $56.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $112.00M 10-Q · filed 2019-08-06 | $190.00M derived: sum of 3 quarters · filed 2020-02-25 | $242.00M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-03-31 | $56.00M 10-Q · filed 2019-05-08 | $134.00M derived: sum of 2 quarters · filed 2020-02-25 | $186.00M derived: sum of 3 quarters · filed 2020-02-25 | $240.00M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2017-12-31 | $78.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $130.00M derived: sum of 2 quarters · filed 2020-02-25 | $184.00M derived: sum of 3 quarters · filed 2020-02-25 | $233.00M 10-K · filed 2020-02-25 | ||||
| 2017-09-30 | $52.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $106.00M derived: sum of 2 quarters · filed 2018-11-06 | $155.00M 10-Q · filed 2018-11-06 | $203.00M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | $54.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $103.00M 10-Q · filed 2018-08-06 | $151.00M derived: sum of 3 quarters · filed 2019-02-26 | $195.00M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | $49.00M 10-Q · filed 2018-05-09 | $97.00M derived: sum of 2 quarters · filed 2019-02-26 | $141.00M derived: sum of 3 quarters · filed 2019-02-26 | $184.00M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2016-12-31 | $48.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $92.00M derived: sum of 2 quarters · filed 2019-02-26 | $135.00M derived: sum of 3 quarters · filed 2019-02-26 | $177.00M 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | $44.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $87.00M derived: sum of 2 quarters · filed 2017-11-07 | $129.00M 10-Q · filed 2017-11-07 | $174.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $43.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $85.00M 10-Q · filed 2017-08-07 | $130.00M derived: sum of 3 quarters · filed 2018-02-27 | $171.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $42.00M 10-Q · filed 2017-05-10 | $87.00M derived: sum of 2 quarters · filed 2018-02-27 | $128.00M derived: sum of 3 quarters · filed 2018-02-27 | $166.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $45.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $86.00M derived: sum of 2 quarters · filed 2018-02-27 | $124.00M derived: sum of 3 quarters · filed 2018-02-27 | $161.00M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $41.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $79.00M derived: sum of 2 quarters · filed 2016-11-07 | $116.00M 10-Q · filed 2016-11-07 | $147.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $38.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $75.00M 10-Q · filed 2016-08-05 | $106.00M derived: sum of 3 quarters · filed 2017-02-27 | $147.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $37.00M 10-Q · filed 2016-05-06 | $68.00M derived: sum of 2 quarters · filed 2017-02-27 | $109.00M derived: sum of 3 quarters · filed 2017-02-27 | $138.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $31.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $72.00M derived: sum of 2 quarters · filed 2017-02-27 | $101.00M derived: sum of 3 quarters · filed 2017-02-27 | $125.00M 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | $41.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $70.00M derived: sum of 2 quarters · filed 2015-11-04 | $94.00M 10-Q · filed 2015-11-04 | $93.67M 10-Q · filed 2014-11-05 | $120.95M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2014-06-30 | $29.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $53.00M 10-Q · filed 2015-08-05 | $53.48M 10-Q · filed 2014-08-04 | $79.95M derived: sum of 3 quarters · filed 2016-02-24 | $105.91M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2014-03-31 | $24.00M 10-Q · filed 2015-05-08 | $24.51M 10-Q · filed 2014-05-07 | $50.95M derived: sum of 2 quarters · filed 2016-02-24 | $76.91M derived: sum of 3 quarters · filed 2016-02-24 | $103.03M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2013-12-31 | $26.95M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $52.91M derived: sum of 2 quarters · filed 2016-02-24 | $79.03M derived: sum of 3 quarters · filed 2016-02-24 | $103.00M 10-K · filed 2016-02-24 | $102.64M 10-K · filed 2014-02-25 | |||
| 2013-09-30 | $25.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $52.07M derived: sum of 2 quarters · filed 2014-11-05 | $76.05M 10-Q · filed 2014-11-05 | $98.56M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-06-30 | $26.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $50.09M 10-Q · filed 2014-08-04 | $72.60M derived: sum of 3 quarters · filed 2015-02-25 | $93.15M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | $23.97M 10-Q · filed 2014-05-07 | $46.48M derived: sum of 2 quarters · filed 2015-02-25 | $67.04M derived: sum of 3 quarters · filed 2015-02-25 | $87.26M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | $22.51M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $43.06M derived: sum of 2 quarters · filed 2015-02-25 | $63.29M derived: sum of 3 quarters · filed 2015-02-25 | $83.00M 10-K · filed 2015-02-25 | $82.85M 10-K · filed 2013-02-27 | |||
| 2012-09-30 | $20.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $40.78M derived: sum of 2 quarters · filed 2013-10-31 | $60.49M 10-Q · filed 2013-10-31 | $79.44M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | $20.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $39.94M 10-Q · filed 2013-08-01 | $58.89M derived: sum of 3 quarters · filed 2014-02-25 | $76.09M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | $19.71M 10-Q · filed 2013-05-08 | $38.66M derived: sum of 2 quarters · filed 2014-02-25 | $55.87M derived: sum of 3 quarters · filed 2014-02-25 | $73.61M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $18.95M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $36.16M derived: sum of 2 quarters · filed 2014-02-25 | $53.90M derived: sum of 3 quarters · filed 2014-02-25 | $72.19M 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | $17.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $34.95M derived: sum of 2 quarters · filed 2012-11-06 | $53.23M 10-Q · filed 2012-11-06 | $71.10M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-30 | $17.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-01 | $36.03M 10-Q · filed 2012-08-01 | $53.90M derived: sum of 3 quarters · filed 2013-02-27 | $69.88M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-03-31 | $18.29M 10-Q · filed 2012-05-04 | $36.15M derived: sum of 2 quarters · filed 2013-02-27 | $52.14M derived: sum of 3 quarters · filed 2013-02-27 | $68.05M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2010-12-31 | $17.86M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $33.85M derived: sum of 2 quarters · filed 2013-02-27 | $49.76M derived: sum of 3 quarters · filed 2013-02-27 | $67.24M 10-K · filed 2013-02-27 | ||||
| 2010-09-30 | $15.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $31.90M derived: sum of 2 quarters · filed 2011-11-04 | $49.38M 10-Q · filed 2011-11-04 | $69.62M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-06-30 | $15.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-05 | $33.39M 10-Q · filed 2011-08-05 | $53.63M derived: sum of 3 quarters · filed 2012-02-23 | $69.12M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-03-31 | $17.48M 10-Q · filed 2011-05-09 | $37.73M derived: sum of 2 quarters · filed 2012-02-23 | $53.21M derived: sum of 3 quarters · filed 2012-02-23 | $68.32M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2009-12-31 | $20.25M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $35.73M derived: sum of 2 quarters · filed 2012-02-23 | $50.84M derived: sum of 3 quarters · filed 2012-02-23 | $64.56M 10-K · filed 2012-02-23 | ||||
| 2009-09-30 | $15.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $30.59M derived: sum of 2 quarters · filed 2010-11-08 | $44.31M 10-Q · filed 2010-11-08 | $58.49M derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-06-30 | $15.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-09 | $28.83M 10-Q · filed 2010-08-09 | $43.00M derived: sum of 3 quarters · filed 2011-02-28 | $56.77M derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-03-31 | $13.72M 10-Q · filed 2010-05-10 | $27.89M derived: sum of 2 quarters · filed 2011-02-28 | $41.66M derived: sum of 3 quarters · filed 2011-02-28 | |||||
| 2008-12-31 | $14.17M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $27.94M derived: sum of 2 quarters · filed 2011-02-28 | $51.72M 10-K · filed 2011-02-28 | |||||
| 2008-09-30 | $13.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | $37.55M 10-Q · filed 2009-11-05 | ||||||
| 2008-06-30 | $23.78M 10-Q · filed 2009-08-05 | |||||||
| 2007-12-31 | $36.89M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |